(Q48829261)

15 February 2018

title

HPA-Axis hormones and prolactin responses to dextro-fenfluramine in depressed patients and healthy controls (English)

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90007-N

23 October 2022

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90007-N

23 October 2022

author name string

D'Hondt P

2

1 reference

15 February 2018

M. Maes

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1662403

23 October 2022

P. D'Hondt

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1662403

23 October 2022

E. Suy

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1662403

23 October 2022

B. Minner

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1662403

23 October 2022

C. Vandervorst

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1662403

23 October 2022

J. Raus

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1662403

23 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1662403

23 October 2022

publication date

1 January 1991

1 reference

15 February 2018

full work available at URL

https://api.elsevier.com/content/article/PII:027858469190007N?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90007-N

https://api.elsevier.com/content/article/PII:027858469190007N?httpAccept=text/plain

23 October 2022

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90007-N

Progress in Neuro-Psychopharmacology & Biological Psychiatry

23 October 2022

published in

1 reference

15 February 2018

volume

15

1 reference

15 February 2018

page(s)

781-790

1 reference

15 February 2018

issue

6

1 reference

15 February 2018

The neuroendocrine response to fenfluramine in depressives and normal controls

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90007-N

Neuroendocrine regulation in depression. II. Discrimination of depressed from nondepressed patients.

23 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90007-N

Serotonin function and mechanism of action of antidepressant treatment. Effects of amitriptyline and desipramine.

23 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90007-N

Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior

23 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90007-N

Abnormalities of indoleamines in affective disorders.

23 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90007-N

Plasma tryptophan and five other amino acids in depressed and normal subjects

23 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90007-N

Neurochemical mechanism of action of drugs which modify feeding via the serotoninergic system

23 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90007-N

From fenfluramine racemate to d-fenfluramine. Specificity and potency of the effects on the serotoninergic system and food intake

23 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90007-N

A rating scale for depression

23 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90007-N

Serotonergic function in depression. Prolactin response to intravenous tryptophan in depressed patients and healthy subjects.

23 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90007-N

Multiple hormone responses to stimulation with dl-fenfluramine in patients with major depression before and after antidepressive treatment

23 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90007-N

The dexamethasone suppression test, the Hamilton Depression Rating Scale and the DSM-III depression categories

23 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90007-N

Relationship between the dexamethasone suppression test and the L-tryptophan/competing amino acids ratio in depression

23 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90007-N

Cortisol, ACTH, prolactin and beta-endorphin responses to fenfluramine administration in major-depressed patients

23 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90007-N

Sex-linked differences in cortisol, ACTH and prolactin responses to 5-hydroxy-tryptophan in healthy controls and minor and major depressed patients

23 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90007-N

The relationships between the cortisol responses to dexamethasone and to L-5-HTP, and the availability of L-tryptophan in depressed females.

23 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90007-N

L-5-hydroxytryptophan stimulated cortisol escape from dexamethasone suppression in melancholic patients

23 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90007-N

Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. I. Enhanced response in depression and mania

23 October 2022

28

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90007-N

Effects of narcotic analgesics on the uptake and release of 5-hydroxytryptamine in rat synaptosomal preparations

23 October 2022

29

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90007-N

Evidence of the existence of two different intraneuronal pools from which pharmacological agents can release serotonin.

23 October 2022

31

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90007-N

Hormonal responses to fenfluramine in depressed and control subjects.

23 October 2022

32

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90007-N

The effects of precursor loading in the cerebral metabolism of 5-hydroxyindoles

23 October 2022

33

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90007-N

Plasma tryptophan and tyrosine ratios to competing amino acids in relation to antidepressant response to citalopram and maprotiline. A preliminary study

23 October 2022

34

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90007-N

Fenfluramine stimulation of serum cortisol in patients with major affective disorders and healthy controls: further evidence for a central serotonergic action of lithium in man

23 October 2022

35

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90007-N

Evidence that it is possible to cause anorexia by increasing release and/or directly stimulating postsynaptic serotonin receptors in the brain.

23 October 2022

37

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90007-N

Plasma prolactin changes following fenfluramine in depressed patients compared to controls: an evaluation of central serotonergic responsivity in depression

23 October 2022

38

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90007-N

Plasma prolactin stimulation by fenfluramine and amphetamine

23 October 2022

39

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90007-N

Hormonal probes of central serotonergic activity: do they really exist?

23 October 2022

42

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90007-N

Plasma cortisol, prolactin, growth hormone, and immunoreactive beta-endorphin response to fenfluramine challenge in depressed patients

23 October 2022

43

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90007-N

Postsynaptic serotonergic activity in depressive patients: evaluation of the neuroendocrine strategy

23 October 2022

44

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90007-N

Monoamine metabolites, corticotropin releasing factor and somatostatin as CSF markers in depressed patients

23 October 2022

46

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90007-N

Research diagnostic criteria and DSM-III: an annotated comparison

23 October 2022

47

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90007-N

23 October 2022

Identifiers

1 reference

15 February 2018

1 reference

15 February 2018